keyword
https://read.qxmd.com/read/38648768/human-blood-serum-counteracts-egfr-her2-targeted-drug-lapatinib-impact-on-squamous-carcinoma-sk-br-3-cell-growth-and-gene-expression
#1
JOURNAL ARTICLE
Nina Shaban, Mikhail Raevskiy, Galina Zakharova, Victoria Shipunova, Sergey Deyev, Maria Suntsova, Maksim Sorokin, Anton Buzdin, Dmitri Kamashev
Lapatinib is a targeted therapeutic inhibiting HER2 and EGFR proteins. It is used for the therapy of HER2-positive breast cancer, although not all the patients respond to it. Using human blood serum samples from 14 female donors (separately taken or combined), we found that human blood serum dramatically abolishes the lapatinib-mediated inhibition of growth of the human breast squamous carcinoma SK-BR-3 cell line. This antagonism between lapatinib and human serum was associated with cancelation of the drug induced G1/S cell cycle transition arrest...
March 2024: Biochemistry. Biokhimii︠a︡
https://read.qxmd.com/read/38624003/-corrigendum-mir%C3%A2-146b%C3%A2-5p-inhibits-tumorigenesis-and-metastasis-of-gallbladder-cancer-by-targeting-toll%C3%A2-like-receptor%C3%A2-4-via-the-nuclear-factor%C3%A2-%C3%AE%C2%BAb-pathway
#2
Bin Ouyang, Ningfeng Pan, Haifeng Zhang, Chuanming Xing, Wu Ji
Following the publication of the article, the authors drew to the Editor's attention that, in Fig. 4D on p. 7, the data correctly shown to represent the E‑cadherin bands for the "NOZ" experiment had inadvertently been used to show the Vimentin bands. However, the authors retained their original data, and the corrected version of Fig. 4, now showing the correct data for the Vimentin bands in Fig. 4D for the "NOZ" experiment, is shown on the next page. Note that this error did not grossly affect either the results or the conclusions reported in this work...
March 2024: Oncology Reports
https://read.qxmd.com/read/38606218/genetic-association-of-toll-like-receptor-4-tlr4-gene-polymorphism-rs4986790-with-oral-squamous-cell-carcinoma-oscc-a-pilot-case-control-study
#3
JOURNAL ARTICLE
Britina Gautam, Anitha Pandi, A S Smiline Girija, Paramasivam Arumugam, Vijayashree J Priyadharsini
Introduction Oral squamous cell carcinoma (OSCC) is a highly prevalent and most common form of oral malignancy in the Indian population. Toll-like receptors belong to an important family of receptors that are involved in the process of pathogen recognition and mounting immune response. The expression of this receptor is dysregulated on the tumor cells as reported across several cancer types. The genetic variants in this gene could have a profound impact on the expression of the Toll-like receptor 4 ( TLR4)  gene...
March 2024: Curēus
https://read.qxmd.com/read/38596014/computational-approach-for-identifying-immunogenic-epitopes-and-optimizing-peptide-vaccine-through-in-silico-cloning-against-mycoplasma-genitalium
#4
JOURNAL ARTICLE
Asma Akter, Natasha Farhin Ananna, Hedayet Ullah, Sirajul Islam, Md Al Amin, K M Kaderi Kibria, Shahin Mahmud
Mycoplasma genitalium is a pathogenic microorganism linked to a variety of severe health conditions including ovarian cancer, prostate cancer, HIV transmission, and sexually transmitted diseases. A more effective approach to address the challenges posed by this pathogen, given its high antibiotic resistance rates, could be the development of a peptide vaccine. In this study, we used experimentally validated 13 membrane proteins and their immunogenicity to identify suitable vaccine candidates. Thus, based on immunogenic properties and high conservation among other Mycoplasma genitalium sub-strains, the P110 surface protein is considered for further investigation...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38583012/dishevelled-segment-polarity-protein-3-dvl3-induced-by-bacterial-lps-promotes-the-proliferation-and-migration-of-prostate-cancer-cells-through-the-tlr4-pathway
#5
JOURNAL ARTICLE
Yakun Zhang, Na Lin, Xianyan Liu, Tingting Yao
BACKGROUND: Chronic inflammation is associated with various malignant tumors. Bacterial lipopolysaccharides (LPSs) play a significant part in the event and development of prostate cancer. Dishevelled segment polarity protein 3 ( DVL3 ) is a shared component of the Wnt/β-catenin and Notch signaling pathways, which are involved in tumor progression, chemoresistance, and maintenance of stem cell-like properties. According to reports, prostatic cancer cell invasion and proliferation are mediated by toll-like receptor 4 ( TLR4 )...
March 2024: Archivos Españoles de Urología
https://read.qxmd.com/read/38577537/advances-in-discovery-of-novel-investigational-agents-for-functional-cure-of-chronic-hepatitis-b-a-comprehensive-review-of-phases-ii-and-iii-therapeutic-agents
#6
REVIEW
Robert Lam, Joseph K Lim
Chronic hepatitis B virus (HBV) infection affects over 295 million people globally and an estimated 1.6 million people in the United States. It is associated with significant morbidity and mortality due to cirrhosis, liver failure, and liver cancer. Antiviral therapy with oral nucleos(t)ide analogues is associated with high rates of virologic suppression, which in turn has been associated with a decreased risk of liver complications. However, current antiviral regimens are limited by concerns with adverse effects, adherence, resistance, long-term treatment, and ongoing risk for liver events...
March 27, 2024: World Journal of Hepatology
https://read.qxmd.com/read/38564478/iron-oxide-nanoparticles-inhibit-tumor-progression-and-suppress-lung-metastases-in-mouse-models-of-breast-cancer
#7
JOURNAL ARTICLE
Preethi Korangath, Lu Jin, Chun-Ting Yang, Sean Healy, Xin Guo, Suqi Ke, Cordula Grüttner, Chen Hu, Kathleen Gabrielson, Jeremy Foote, Robert Clarke, Robert Ivkov
Systemic exposure to starch-coated iron oxide nanoparticles (IONPs) can stimulate antitumor T cell responses, even when little IONP is retained within the tumor. Here, we demonstrate in mouse models of metastatic breast cancer that IONPs can alter the host immune landscape, leading to systemic immune-mediated disease suppression. We report that a single intravenous injection of IONPs can inhibit primary tumor growth, suppress metastases, and extend survival. Gene expression analysis revealed the activation of Toll-like receptor (TLR) pathways involving signaling via Toll/Interleukin-1 receptor domain-containing adaptor-inducing IFN-β (TRIF), a TLR pathway adaptor protein...
April 2, 2024: ACS Nano
https://read.qxmd.com/read/38555283/network-pharmacology-computational-biology-integrated-surface-plasmon-resonance-technology-reveals-the-mechanism-of-ellagic-acid-against-rotavirus
#8
JOURNAL ARTICLE
Jiangang Zheng, Abdul Haseeb, Ziyang Wang, Hejie Wang
The target and mechanism of ellagic acid (EA) against rotavirus (RV) were investigated by network pharmacology, computational biology, and surface plasmon resonance verification. The target of EA was obtained from 11 databases such as HIT and TCMSP, and RV-related targets were obtained from the Gene Cards database. The relevant targets were imported into the Venny platform to draw a Venn diagram, and their intersections were visualized. The protein-protein interaction networks (PPI) were constructed using STRING, DAVID database, and Cytoscape software, and key targets were screened...
March 30, 2024: Scientific Reports
https://read.qxmd.com/read/38516781/sesn1-functions-as-a-new-tumor-suppressor-gene-via-toll-like-receptor-signaling-pathway-in-neuroblastoma
#9
JOURNAL ARTICLE
Zhongyan Hua, Bo Chen, Baocheng Gong, Meizhen Lin, Yifan Ma, Zhijie Li
AIMS: Neuroblastoma (NB) is the most common extracranial solid tumor in children, with a 5-year survival rate of <50% in high-risk patients. MYCN amplification is an important factor that influences the survival rate of high-risk patients. Our results indicated MYCN regulates the expression of SESN1. Therefore, this study aimed to investigate the role and mechanisms of SESN1 in NB. METHODS: siRNAs or overexpression plasmids were used to change MYCN, SESN1, or MyD88's expression...
March 2024: CNS Neuroscience & Therapeutics
https://read.qxmd.com/read/38503239/rna-is-a-pro-apoptotic-target-of-cisplatin-in-cancer-cell-lines-and-c-elegans
#10
JOURNAL ARTICLE
Fabian Rose, Beate Köberle, Sebastian Honnen, Cindy Bay, Jürgen Burhenne, Johanna Weiss, Walter E Haefeli, Dirk Theile
Cisplatin not only targets DNA but also RNA. However, it is largely unknown whether platinated RNA (Pt-RNA) causes apoptosis and thus contributes to the cytotoxic effects of cisplatin. Consequently, cellular RNA was isolated from HepG2 and LS180 cells, exposed to cisplatin, and the resulting Pt-RNA (20 ng Pt/µg RNA) was transfected into these cancer cell lines or used to treat an apoptosis reporter Caenorhabditis elegans (C. elegans) strain (MD701, expressing CED-1::GFP). Cellular and molecular effects of Pt-RNA were evaluated by luminogenic caspase 3/7 assays, PCR array analysis, and fluorescence microscopy-based quantification of apoptosis in C...
March 18, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38498304/design-and-synthesis-of-3-2-h-chromen-3-yl-5-aryl-1-2-4-oxadiazole-derivatives-as-novel-toll-like-receptor-2-1-agonists-that-inhibit-lung-cancer-in-vitro-and-in-vivo
#11
JOURNAL ARTICLE
Yijie Wang, Xu Cheng, Xinru Liu, Jing Xu, Lin Wang, Shouguo Zhang, Shuchen Liu, Tao Peng
Toll-like receptor (TLR) 2 is a transmembrane receptor that participates in the innate immune response by forming a heterodimer with TLR1 or TLR6. TLR2 agonists play an important role in tumor therapy. Herein, we synthesized a series of 3-(2 H -chromen-3-yl)-5-aryl-1,2,4-oxadiazole derivatives and identified WYJ-2 as a potent small and selective molecule agonist of TLR2/1, with an EC50 of 18.57 ± 0.98 nM in human TLR2 and TLR1 transient-cotransfected HEK 293T cells. WYJ-2 promoted the formation of TLR2/1 heterodimers and activated the nuclear factor kappa B (NF-κB) signaling pathway...
March 18, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38491184/fine-tuning-of-cpg-spatial-distribution-with-dna-origami-for-improved-cancer-vaccination
#12
JOURNAL ARTICLE
Yang C Zeng, Olivia J Young, Christopher M Wintersinger, Frances M Anastassacos, James I MacDonald, Giorgia Isinelli, Maxence O Dellacherie, Miguel Sobral, Haiqing Bai, Amanda R Graveline, Andyna Vernet, Melinda Sanchez, Kathleen Mulligan, Youngjin Choi, Thomas C Ferrante, Derin B Keskin, Geoffrey G Fell, Donna Neuberg, Catherine J Wu, David J Mooney, Ick Chan Kwon, Ju Hee Ryu, William M Shih
Multivalent presentation of ligands often enhances receptor activation and downstream signalling. DNA origami offers a precise nanoscale spacing of ligands, a potentially useful feature for therapeutic nanoparticles. Here we use a square-block DNA origami platform to explore the importance of the spacing of CpG oligonucleotides. CpG engages Toll-like receptors and therefore acts to activate dendritic cells. Through in vitro cell culture studies and in vivo tumour treatment models, we demonstrate that square blocks induce Th1 immune polarization when CpG is spaced at 3...
March 15, 2024: Nature Nanotechnology
https://read.qxmd.com/read/38488815/rintatolimod-in-advanced-pancreatic-cancer-enhances-anti-tumor-immunity-through-dendritic-cell-mediated-t-cell-responses
#13
JOURNAL ARTICLE
Casper W F van Eijck, Hassana El Haddaoui, Songul Kucukcelebi, Disha Vadgama, Amine Fellah, Dana A M Mustafa, Joachim G J V Aerts, Casper H J van Eijck, Marcella Willemsen
PURPOSE: Amid the need for new approaches to improve survival in pancreatic ductal adenocarcinoma (PDAC), immune-based therapies have garnered interest. Rintatolimod, a toll-like receptor 3 (TLR-3) agonist, is a potential candidate due to its dual impact on restraining PDAC cell functions and boosting the anti-tumor immune response. This study investigates the effect of TLR-3 activation through rintatolimod on the peripheral immune landscape of advanced PDAC patients. PATIENTS AND METHODS: Paired blood samples of 30 patients with advanced PDAC, collected at baseline and after 12 rintatolimod intravenous infusions, underwent comprehensive transcriptomic NanoString and proteomic flow cytometry profiling...
March 15, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38486995/biomimetic-gemini-nanoimmunoregulators-orchestrated-for-boosted-photoimmunotherapy-by-spatiotemporally-modulating-pd-l1-and-tumor-associated-macrophages
#14
JOURNAL ARTICLE
Honglin Huang, Ningxi Li, Xiaodan Wei, Qingzhi Li, Junhan Guo, Geng Yang, Hong Yang, Lulu Cai, Yiyao Liu, Chunhui Wu
A novel strategy of not only stimulating the immune cycle but also modulating the immunosuppressive tumor microenvironment is of vital importance to efficient cancer immunotherapy. Here, a new type of spatiotemporal biomimetic "Gemini nanoimmunoregulators" was engineered to activate robust systemic photoimmunotherapy by integrating the triple-punch of amplified immunogenic cell death (ICD), tumor-associated macrophages (TAMs) phenotype reprogramming and programmed cell death ligand 1 (PD-L1) degradation. The "Gemini nanoimmunoregulators" PM@RM-T7 and PR@RM-M2 were constructed by taking the biocompatible mesoporous polydopamine (mPDA) as nanovectors to deliver metformin (Met) and toll-like receptor 7/8 agonist resiquimod (R848) to cancer cells and TAMs by specific biorecognition via wrapping of red blood cell membrane (RM) inlaid with T7 or M2 peptides...
March 2024: Acta Pharmaceutica Sinica. B
https://read.qxmd.com/read/38483660/tmem2-suppresses-tlr3-mediated-ifn-%C3%AE-isg56-cxcl10-expression-in-beas-2b-bronchial-epithelial-cells
#15
JOURNAL ARTICLE
Yuri Kobori, Mayuki Tachizaki, Tadaatsu Imaizumi, Yusuke Tanaka, Kazuhiko Seya, Yasuo Miki, Shogo Kawaguchi, Tomoh Matsumiya, Yuki Tobisawa, Chikara Ohyama, Sadatomo Tasaka
BACKGROUND: Bronchial epithelial cells are at the front line of viral infections. Toll-like receptor 3 (TLR3) cascade causes the expression of interferon (IFN)-β and IFN-stimulated genes (ISGs), which in turn induce an antiviral response. Members of the transmembrane protein (TMEM) family are expressed in various cell types. Although the prognostic value of TMEM2 in various cancers has been reported, its association with infectious diseases remains unknown. In this study, we investigated the effects of TMEM2 on antiviral immunity in BEAS-2B bronchial epithelial cells...
March 14, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38476167/mechanisms-of-mesothelial-cell-response-to-viral-infections-hdac1-3-inhibition-blocks-poly-i-c-induced-type-i-interferon-response-and-modulates-the-mesenchymal-inflammatory-phenotype
#16
JOURNAL ARTICLE
Flavia Trionfetti, Claudia Montaldo, Ivan Caiello, Giulio Bontempi, Michela Terri, Marta Tiberi, Vanessa Marchant, Alessandro Domenici, Paolo Menè, Marco Cordani, Clemens Zwergel, Giusi Prencipe, Marta Ruiz-Ortega, Sergio Valente, Antonello Mai, Marco Tripodi, Raffaele Strippoli
Infectious peritonitis is a leading cause of peritoneal functional impairment and a primary factor for therapy discontinuation in peritoneal dialysis (PD) patients. Although bacterial infections are a common cause of peritonitis episodes, emerging evidence suggests a role for viral pathogens. Toll-like receptors (TLRs) specifically recognize conserved pathogen-associated molecular patterns (PAMPs) from bacteria, viruses, and fungi, thereby orchestrating the ensuing inflammatory/immune responses. Among TLRs, TLR3 recognizes viral dsRNA and triggers antiviral response cascades upon activation...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38463226/prognostic-and-clinicopathological-significance-of-tlr4-expression-in-patients-with-breast-cancer-a-meta-analysis
#17
REVIEW
Jinxu Wen, Jiayi Zhang, Xiaoyong Wu, Xuemin Yan, Xiaoru Qin, Yuexin Wang
BACKGROUND: The prognostic value of Toll-like receptor 4 (TLR4) in breast cancer remains to be determined. Therefore, this paper aims to conduct a meta-analysis to assess the correlation between TLR4 and clinicopathological indicators as well as survival outcomes in breast cancer. METHOD: Related literature retrieved from Embase, PubMed, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI) and China Wanfang. The search deadline is April 12, 2023...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38457336/leishmania-braziliensis-enhances-monocyte-responses-to-promote-anti-tumor-activity
#18
JOURNAL ARTICLE
Jéssica Cristina Dos Santos, María Moreno, Lisa U Teufel, Sofía Chilibroste, Samuel T Keating, Laszlo Groh, Jorge Domínguez-Andrés, David L Williams, Zuchao Ma, Douglas W Lowman, Harry E Ensley, Boris Novakovic, Fátima Ribeiro-Dias, Mihai G Netea, José A Chabalgoity, Leo A B Joosten
Innate immune cells can undergo long-term functional reprogramming after certain infections, a process called trained immunity (TI). Here, we focus on antigens of Leishmania braziliensis, which induced anti-tumor effects via trained immunity in human monocytes. We reveal that monocytes exposed to promastigote antigens of L. braziliensis develop an enhanced response to subsequent exposure to Toll-like receptor (TLR)2 or TLR4 ligands. Mechanistically, the induction of TI in monocytes by L. braziliensis is mediated by multiple pattern recognition receptors, changes in metabolism, and increased deposition of H3K4me3 at the promoter regions of immune genes...
March 7, 2024: Cell Reports
https://read.qxmd.com/read/38442944/spink5-inhibits-esophageal-squamous-cell-carcinoma-metastasis-via-immune-activity
#19
JOURNAL ARTICLE
Jie Chen, Juncheng Lu, Zhiqiang Chen, Zihao Liu, Yuejun Sun, Shuyan He, Yedong Mi, Yi Gao, Dong Shen, Qingfeng Lin
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is a predominant subtype of esophageal cancer with relatively high mortality worldwide. Serine peptidase inhibitor Kazal-type 5 (SPINK5) is reported to be downregulated in ESCC. However, its explicit role in ESCC remains further investigation. METHODS: The tumor tissues and adjacent non-cancerous tissues were obtained from 196 patients with ESCC for the determination of SPINK5 mRNA levels. Additionally, the relationship between SPINK5 mRNA levels and clinicopathological features of ESCC patients was explored...
March 2024: Journal of Gene Medicine
https://read.qxmd.com/read/38434966/application-of-bioinformatics-in-predicting-the-efficacy-of-digestive-tumour-immunotherapy-target-tim-3-and-its-inhibitors
#20
JOURNAL ARTICLE
Zexin Wang, Xibin Li, Litao Tian, Dan Sha, Qinhui Sun, Jinshen Wang
Background: Our main objective is to apply bioinformatics in predicting the efficacy of digestive tumour immunotherapy target TIM-3 and its inhibitors. Methods: Our study used the gene expression omnibus (GEO) database to identify datasets associated with digestive tumours and the action of TIM-3. The GSE427729 dataset based on the GPL10192 platform. The dataset consisted of six samples of total RNA derived from TIM-3 control and knockdown RAW 264.7 cells. We used GEO2R tool to identify DEGs before performing Gene Ontology and identifying the kyoto encyclopedia of genes and genomes (KEGG) pathways...
2024: Journal of Cancer
keyword
keyword
85426
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.